Evaluating Teen-Parent Dynamics in Adolescent COVID-19 Vaccine Acceptance and Uptake

评估青少年家长对青少年 COVID-19 疫苗接受和使用的动态

• 批准号: 10510299
• 负责人: Annette Karena Regan
• 金额: $ 19.51万
• 依托单位: UNIVERSITY OF SAN FRANCISCO
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-08-15 至 2024-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10510299
• 关键词: 12 year old; 17 year old; Address; Adolescent; Adult; Attitude; Behavior; COVID-19; COVID-19 impact; COVID-19 monitoring; COVID-19 mortality; COVID-19 pandemic; COVID-19 vaccination; COVID-19 vaccine; Cessation of life; Child; Communities; Consent; Data; Data Collection; Decision Making; Development; Disease; District of Columbia; Dose; Educational Intervention; Ethnic Origin; Future; Geographic state; Health; Health Benefit; Health Knowledge Attitudes Practice; Hospitalization; Immunization; Immunize; Incidence; Individual; Infection; Intervention; Joints; Measurement; Measures; Methods; Morbidity - disease rate; Parents; Policies; Population; Predictive Factor; Prevention; Process; Public Health; Race; Recommendation; Reporting; Research; Risk; SARS-CoV-2 B.1.617.2; SARS-CoV-2 transmission; Schools; Surveys; Teenagers; Testing; Time; Vaccinated; Vaccination; Vaccines; Virus; aged; experience; falls; global health; health care availability; health care service; high school; hospitalization rates; improved; infection risk; innovation; junior high school; novel; novel strategies; pandemic disease; parental influence; public health priorities; sex; social factors; social health determinants; sociodemographic factors; therapy development; tool; unvaccinated; uptake; vaccine acceptance; vaccine hesitancy; vaccine safety

PROJECT SUMMARY Although early in the COVID-19 pandemic, the majority of hospitalizations and deaths occurred among adults, since the rise of the delta variant in the US, hospitalizations among adolescents have steadily increased. Between June and August 2021, the hospitalization rate for adolescents with COVID-19 increased five-fold. In addition to the direct health consequences of COVID-19, adolescents are a key group for mitigating the transmission of the SARS-CoV-2 virus. The reopening of middle and high-schools creates additional opportunities for sustained transmission of COVID-19 in the community, making prevention of adolescent infection a public health priority for COVID-19 control. COVID-19 vaccination is recommended for all individuals 12 years and older and reduces the risk of infection and adolescent hospitalization with COVID-19. Despite the public health benefits, immunization rates are suboptimal among US adolescents. As of July 31, 2021, 42% of US adolescents aged 12-17 years old have received ≥1 dose of the COVID-19 vaccine and 32% were fully vaccinated. These rates fall well below the national average of 76% of the US population ≥12 years of age with ≥1 dose of the COVID-19 vaccine and the 65% fully vaccinated. Historically, interventions to improve adolescent vaccine coverage have almost exclusively targeted parents. As a result, we currently have a poor understanding of vaccine hesitancy among adolescents and how this relates to vaccine decision-making. Given a) poor COVID-19 immunization rates observed among adolescents, b) the fact that more than 30% of adolescents report being involved in vaccine decision-making, and c) the recent expansion of state policies to allow adolescent consent to vaccination, examination of joint and independent adolescent and parental vaccine attitudes and how these attitudes drive vaccine acceptance is critically needed to more effectively control the spread of COVID-19. Through an innovative approach to data collection and novel application of an existing statistical framework, we aim to i) validate a measurement tool for monitoring COVID-19 vaccine hesitancy in adolescents and their parents, ii) identify how this hesitancy correlates between adolescents and their parents and iii) evaluate how adolescent and parental vaccine hesitancy interacts in the decision to vaccinate against COVID-19. Interventions that exclusively target parents are less likely to be effective compared to multilevel interventions targeting both adolescents and their parents. Evidence generated by this application will be used to develop such interventions. In future, this framework could be applied to improve uptake of other recommended adolescent vaccines.

项目总结 虽然在新冠肺炎大流行的早期，大多数住院和死亡发生在成年人中， 自从Delta变种在美国兴起以来，青少年的住院人数一直在稳步增加。 2021年6月至8月，患有新冠肺炎的青少年住院率增加了五倍。在……里面 除了新冠肺炎对健康的直接影响外，青少年是缓解糖尿病的关键群体 SARS-CoV-2病毒的传播。初中和高中的重新开学创造了额外的 新冠肺炎在社区持续传播的机会，使青少年预防 感染是新冠肺炎控制的公共卫生优先事项。 建议12岁及以上人士接种新冠肺炎疫苗，可减低感染风险。 和青少年住院与新冠肺炎。尽管对公众健康有益，但免疫接种率是 在美国青少年中不是最理想的。截至2021年7月31日，42%的12-17岁美国青少年患有 ≥接种了1剂新冠肺炎疫苗，32%的人接种了完整疫苗。这些利率远远低于 全国平均76%的美国人口在12岁时接种了1剂新冠肺炎疫苗和≥≥ 65%的人完全接种了疫苗。从历史上看，提高青少年疫苗覆盖率的干预措施几乎 专门针对父母。因此，我们目前对疫苗的犹豫不决的理解很差。 以及这与疫苗决策的关系。鉴于a)新冠肺炎接种率较低 在青少年中观察到，b)超过30%的青少年报告参与了疫苗接种 决策，以及c)最近扩大了国家政策，允许青少年同意接种疫苗， 检查青少年和父母联合和独立的疫苗接种态度以及这些态度如何推动 为了更有效地控制新冠肺炎的传播，接受疫苗是至关重要的。 通过数据收集的创新办法和现有统计框架的新应用， 我们的目标是：i)验证一种监测青少年和他们的新冠肺炎疫苗接种迟疑率的测量工具 父母，二)确定青少年和他们的父母之间这种犹豫不决的关系，以及三)如何评估 青少年和父母在接种新冠肺炎疫苗的决定中存在相互作用。 与多层次干预相比，专门针对父母的干预措施不太可能有效 针对青少年和他们的父母。此应用程序生成的证据将用于开发 这样的干预。在未来，这一框架可以应用于改善对其他建议的吸收 青少年疫苗。